Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1R01DK147509-01 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | NIH |
Not provided
Not provided
Not provided
About 6.5 million adults in the United States who are 65 or older have dementia.
While the exact cause of dementia is not known, it may be due to changes in the brain. Further, risk may be higher when the brain does not respond to insulin. Indeed, brain insulin resistance has emerged as a pathologic factor affecting memory, executive function as well as systemic glucose control. Regular aerobic exercise may help reduce the risk of dementia by increased blood flow to the brain and help the brain respond better to insulin. In addition, giving insulin through a nose spray (called intranasal insulin) may also help with thinking and memory. However, it is unknown if using both exercise and intranasal insulin is best for the brain.
This goal of this study is to find out if exercise plus an insulin nose spray works better than exercise alone for brain blood flow in older adults with Type 2 Diabetes. This study will also look at how the brain uses insulin and thinking skills. Individuals will be randomized to one of two groups. One group will exercise and use an insulin nose spray. The other group will exercise and use a saline (placebo) nose spray. Exercise training will be supervised and consist of walking or light jogging 3 times per week for 16 weeks. Brain imaging, cognition, and blood tests will be conducted before and after the intervention. Other measures include fitness tests and body composition scans.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HiEx with Intranasal Placebo | Placebo Comparator |
| |
| HiEx with Intranasal Insulin | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intranasal Insulin | Drug | Dosage will be 20 IU of INI twice per day (40 IU in total/day). The study will use the Kurve Technology intranasal device, which delivers a 20 second stream of insulin through a nose piece into a nostril, after which the device switches off. The process will then be repeated in the other nostril. |
| Measure | Description | Time Frame |
|---|---|---|
| Cerebrovascular Insulin Sensitivity | People will undergo a motion corrected diffusion weighted gradient-and spin echo pseudo-Continuous Arterial Spin Labeling (pCASL) sequence with 5 post labelling delays. This provides 3.5 mm3 resolution for whole brain coverage for CBF. CBF will be determined via the hippocampus. Participants will then be administrated INI at a dose of 40 IU of human insulin (0.4 ml, Humulin, Eli Lilly & Co., Indianapolis, IN). Single puffs of 0.1ml will occur 4 times (twice each nostril) over 2 minutes via the VianaseTM electronic atomizers (Kurve Technology Inc., Lynnwood, WA). After 30 minutes, scanning will be repeated to determine CBF changes to indicate brain insulin sensitivity. Brain insulin sensitivity will be defined as the change from fasting to INI (e.g. CBFINI - CBFfast). | Change from baseline to the end of the intervention at 16 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Blood Brain Barrier Integrity | People will undergo a motion corrected diffusion weighted gradient-and spin echo pseudo-Continuous Arterial Spin Labeling (pCASL) sequence with 5 post labelling delays. This provides 3.5 mm3 resolution for whole brain coverage for BBB water exchange (Kw). Kw will serve as primary index of BBB integrity. Participants will then be administrated INI at a dose of 40 IU of human insulin (0.4 ml, Humulin, Eli Lilly & Co., Indianapolis, IN). Single puffs of 0.1ml will occur 4 times (twice each nostril) over 2 minutes via the VianaseTM electronic atomizers (Kurve Technology Inc., Lynnwood, WA). After 30 minutes, scanning will be repeated to determine BBB changes from fasting to INI (e.g. KwINI - Kwfast). |
Not provided
Inclusion Criteria:
Exclusion Criteria:
A diagnosis of dementia
Neurologic disease (e.g. Parkinson's, autonomic neuropathy, etc.)
Intolerance to insulin
Morbidly obese patients (BMI >40 kg/m2) and lean patients (BMI <25 kg/m2)
>2 kg weight change in past 6 months
Participants who have been recently active (>90 min of moderate/high intensity exercise)
Individuals who are smokers or who have quit smoking (<2 years)
Hypertriglyceridemia (400 mg/dl) and hypercholesterolemic (>260 mg/dl) subjects
Uncontrolled Hypertensive (>160/100 mmHg)
Participants with a history of significant metabolic, cardiac, cerebrovascular, hematological, pulmonary, gastrointestinal, liver, renal, or endocrine disease or cancer that in the investigator's opinion would interfere with or alter the outcome measures, or impact subject safety
Pregnant (as evidenced by positive pregnancy test) or nursing women
Participants with contraindications to participation in an exercise training program
Major psychiatric disorders (e.g. psychosis, bipolar disorder, major depression, alcohol/substance abuse)
History of head trauma or loss of consciousness in last 5 years.
Known contraindications for MR imaging:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Steven K Malin, PhD | Contact | 848-932-7540 | steven.malin@rutgers.edu | |
| Emily M Heiston, PhD | Contact | 848-932-7540 | emily.heiston@rutgers.edu |
| Name | Affiliation | Role |
|---|---|---|
| Steven K Malin, PhD | Rutgers University - New Brunswick | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Robert Wood Johnson University Hospital Clinical Research Center | Recruiting | New Brunswick | New Jersey | 08091 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41876945 | Background | Malin SK, Battillo DJ, Beeri MS, Mustapic M, Kapogiannis D. A Single Bout of Aerobic Exercise Increases Neuronal Extracellular Vesicle-Derived Insulin Signaling Biomarkers in Adults With Cardiometabolic Risk. Compr Physiol. 2026 Apr;16(2):e70131. doi: 10.1002/cph4.70131. | |
| 41978122 | Background | Malin SK, Battillo DJ, Zald DH, Ramirez J. Appetite Perception and Cerebral Blood Flow in Aging Adults Following a Single Bout of Exercise. Nutrients. 2026 Mar 27;18(7):1072. doi: 10.3390/nu18071072. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| D007333 | Insulin Resistance |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000072696 | High-Intensity Interval Training |
| ID | Term |
|---|---|
| D064797 | Physical Conditioning, Human |
| D015444 | Exercise |
| D009043 | Motor Activity |
| D009068 | Movement |
Not provided
Not provided
Participants will be randomly assigned to receive high intensity exercise training with intranasal insulin or high intensity exercise training with intranasal placebo.
Not provided
Not provided
Not provided
|
| Intranasal Placebo | Drug | Saline will be administered twice daily (20 seconds in each nostril) using the Kurve Technology intranasal insulin device. |
|
| High Intensity Exercise | Behavioral | High intensity exercise will consist of 16 weeks of walking at ~85% of each participant's predetermined VO2max and monitored via heart rate. Supervised exercised will occur on a treadmill 3d/wk. The duration of each exercise session will be adjusted based on fitness level so that ~300 kcal will be expended per training session during weeks 1-2, 350 kcal per training session during weeks 3-4, and 400 kcal per training session during weeks 5-16. This usually equals ~60 minutes per session but can vary from person to person. Each session will start with a 5-minute warm-up and end with a 5-minute cool down. During each exercise session, individuals will wear a heart rate monitor rating of perceived exertion will be recorded. |
|
| Change from baseline to the end of the intervention at 16 weeks |
| Insulin Signaling Proteins | Insulin signaling proteins pIRS-1Ser636 and pAktSer473, derived from neuronal extracellular vesicles (nEVs) will be measured before and 30 minutes after intranasal insulin (e.g. nEVsINI - nEVsfast). nEVs will be isolated from plasma samples through a 2-step method: 1) isolating total plasma nEVs via Size Exclusion Chromatography (SEC) and selective immunocapture targeting three neuronal-specific epitopes on intact EVs (L1CAM, NLGN3, and GAP43). Isolated nEVs concentration and size distribution will be assessed by nanoparticle tracking analysis (NTA). nEV concentration will be used to normalize protein biomarker values to account for differential recovery. | Change from baseline to the end of the intervention at 16 weeks |
| Augmentation Index | Brachial artery augmentation index (AIx75) will be tested in the semi-supine position using the SphygmoCor device to depict arterial stiffness before and after INI (e.g. AIx75INI - AIx75fast). | Change from baseline to the end of the intervention at 16 weeks |
| Peripheral Insulin Sensitivity | A 120 minute 75g OGTT will be used to depict insulin sensitivity. | Change from baseline to the end of the intervention at 16 weeks |
| Cognitive Function | Cognitive function will be assessed via the NIH toolbox. The NIH toolbox is an iPad application that consists of cognitive, emotional, motor, and sensory function assessments. Specific measurements will include: Flanker Inhibitory Control and Attention Test, List Sorting Working Memory Test, Pattern Comparison Processing Speed Test, and Picture Sequence Memory Test. | Change from baseline to the end of the intervention at 16 weeks |
| Pulse Wave Velocity | Pulse Wave Velocity (PWV) will be tested in the semi-supine position using the SphygmoCor device to depict arterial stiffness before and after INI (i.e. PWV-INI - PWV-fast). | Change from baseline to the end of the intervention at 16 weeks |
| Insulin Secretion | A 120 minute 75g OGTT will be used to depict insulin secretion. Using the oral c-peptide minimal model (OMM), an estimate of 3 insulin secretion patterns will be be obtained: 1) one that is proportional to glucose rate change (i.e. early phase); 2) another proportional to plasma glucose above a threshold after a delay (i.e. late phase); and 3) total responsivity index, (total phase). | Change from baseline to the end of the intervention at 16 weeks |
| Institute for Food, Nutrition, and Health | Recruiting | New Brunswick | New Jersey | 08901 | United States |
|
| Rutgers University Loree Gymnasium | Recruiting | New Brunswick | New Jersey | 08901 | United States |
|
| Center for Advanced Human Brain Imaging Research | Recruiting | Piscataway | New Jersey | 08854 | United States |
|
| 42295834 | Background | Malin SK, Zald DH, Battillo D. Acute Exercise Reduces Intranasal Insulin-Mediated Elevations in Blood Pressure in Aging Adults with Cardiometabolic Risk. Am J Physiol Regul Integr Comp Physiol. 2026 Jun 15. doi: 10.1152/ajpregu.00119.2026. Online ahead of print. |
| 39421964 | Background | Malin SK, Battillo DJ, Beeri MS, Mustapic M, Delgado-Peraza F, Kapogiannis D. Two weeks of exercise alters neuronal extracellular vesicle insulin signaling proteins and pro-BDNF in older adults with prediabetes. Aging Cell. 2025 Jan;24(1):e14369. doi: 10.1111/acel.14369. Epub 2024 Oct 18. |
| D004700 | Endocrine System Diseases |
| D006946 | Hyperinsulinism |
| D009142 |
| Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |